GALVmed launches its new website

We are pleased to announce the launch of our brand new website! After months of hard work and dedication, we are delighted to present the newly designed website available at

The goal of our new website is to provide our visitors with an easier and more efficient way to learn about how we make livestock vaccines, medicines and diagnostics sustainably available and accessible to the millions of small-holder livestock keepers in developing countries. The new website is interactive. It is now easier to find information about us, our work and the impact our programmes are having on the lives of small-holder farmers in Africa and South Asia. Our Protecting Livestock blog features case studies and insights on the value of livestock vaccines.

We will be constantly updating our content with information, articles, blogs, newsletters and will also continue to interact with our visitors through our social media sites, which can be easily accessed anywhere on our website. We hope you find the new website informative and easily accessible. 

For any questions, suggestions, feedback or comments, please e-mail us.

 Public-private partnership brings the benefit of livestock vaccines to small-holder farmers in Jharkhand, India

GALVmed is proud to have brokered a first of its kind public-private partnership between Hester Biosciences Limited, an Indian commercial animal health company, Jharkhand State Livelihood Promotion Society (JSLPS), an independent and autonomous society of the Government of Jharkhand, India.  Hester Biosciences will produce LaSota, a thermo-tolerant Newcastle Disease vaccine and will establish an innovative business model to deliver customised livestock health products for small-holder livestock keepers. This unique model sees a commercial company establishing a market in the small-holder sector, which is conventionally ignored by the livestock industry. Partnership with JSLPS will be critical in delivery of the vaccine and in establishing a sustainable delivery model.

Read more

GALVmed has been asked to be involved in a Brucellosis vaccine pilot project for the development of an improved, safe, low-cost & efficacious vaccine for Brucella melitensis. The project will involve a significant prize for the company that manages to develop and register a safe and efficacious brucellosis vaccine in the EU, as well as two attractive milestone payments for the successful participants as they move along the vaccine development process.
This project will require an experienced project team leader and so GALVmed is looking for a Project Manager to lead all day-to-day and strategic elements of the project. For more information or to apply, visit our website. Application closes on 7th February.

Fighting Newcastle Disease in Tanzania

Each month, we share a story of how GALVmed and our partners are making a difference in the lives of small-holder farmers in Africa and South Asia. This month, find out how a model of private-public partnership is fighting against Newcastle Disease in Tanzania using a thermostable I-2 vaccine.

Galvanising action against Newcastle Disease in Tanzania
On our Protecting Livestock blog
GALVmed's Facebook
GALVmed's Facebook
GALVmed's Twitter
GALVmed's Twitter
GALVmed's website
GALVmed's website
Copyright © 2016 GALVmed, All rights reserved.

unsubscribe from this list    update subscription preferences 

Registered Charity in Scotland: SC039197 Registered Charity in England and Wales: 1115606.
Registered Name: Global Alliance for Livestock Veterinary Medicines.
Registered in England and Wales No. 5393391, limited by guarantee.
Registered Office: Maclay Murray & Spens, One London Wall, London EC2Y 5AB, UK.

Email Marketing Powered by Mailchimp